Viewing Study NCT05311566


Ignite Creation Date: 2025-12-24 @ 4:19 PM
Ignite Modification Date: 2026-01-07 @ 5:31 AM
Study NCT ID: NCT05311566
Status: RECRUITING
Last Update Posted: 2022-04-13
First Post: 2022-03-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer
Sponsor: Lei Li
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module